Esthesioneuroblastoma laboratory findings
Jump to navigation
Jump to search
|
Esthesioneuroblastoma Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Esthesioneuroblastoma laboratory findings On the Web | |
|
American Roentgen Ray Society Images of Esthesioneuroblastoma laboratory findings | |
|
Risk calculators and risk factors for Esthesioneuroblastoma laboratory findings | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
Laboratory findings consistent with the diagnosis of [disease name] include hypercalcemia, syndrome of inappropriate antidiuretic hormone (SIADH), hyponatremia, and neurological paraneoplastic syndromes.
Laboratory Findings
Laboratory findings consistent with the diagnosis of esthesioneuroblastoma include the following:[1][2][3][4][5]
- Ectopic adrenocorticotropic hormone syndrome
- Hypercalcemia
- Syndrome of inappropriate antidiuretic hormone (SIADH)
- Hyponatremia
- Neurological paraneoplastic syndromes
References
- ↑ Ward PD, Heth JA, Thompson BG, Marentette LJ (2009). "Esthesioneuroblastoma: Results and Outcomes of a Single Institution's Experience". Skull Base. 19 (2): 133–40. doi:10.1055/s-0028-1096195. PMC 2671304. PMID 19721769.
- ↑ Koo BK, An JH, Jeon KH, Choi SH, Cho YM, Jang HC; et al. (2008). "Two cases of ectopic adrenocorticotropic hormone syndrome with olfactory neuroblastoma and literature review". Endocr J. 55 (3): 469–75. PMID 18469486.
- ↑ Sharma S, Lasheen W, Walsh D (2008). "Paraneoplastic refractory hypercalcemia due to advanced metastatic esthesioneuroblastoma". Rhinology. 46 (2): 153–5. PMID 18575019.
- ↑ Gabbay U, Leider-Trejo L, Marshak G, Gabbay M, Fliss DM (2013). "A case and a series of published cases of esthesioneuroblastoma (ENB) in which long-standing paraneoplastic SIADH had preceded ENB diagnosis". Ear Nose Throat J. 92 (10–11): E6. PMID 24170477.
- ↑ Kunc M, Gabrych A, Czapiewski P, Sworczak K (2015). "Paraneoplastic syndromes in olfactory neuroblastoma". Contemp Oncol (Pozn). 19 (1): 6–16. doi:10.5114/wo.2015.46283. PMC 4507891. PMID 26199564.